Penumbra, Inc. Income Statement
PEN / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
Penumbra, Inc. reported $1.4B in revenue and $178M in net income for FY2025. Revenue has grown at a 25.9% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.2B | $1.1B | $560.4M | $547.4M | $560.4M | $333.8M | $263.3M | $186.1M | $263.3M | $186.1M | $125.5M | $88.8M |
| Cost of Revenue | $461.2M | $439.6M | $375.9M | $222.2M | $175.4M | $222.2M | $116.6M | $92.5M | $62.0M | $92.5M | $62.0M | $42.7M | $31.0M |
| Gross Profit | $942.4M | $755.0M | $682.6M | $338.2M | $372.0M | $338.2M | $217.1M | $170.8M | $124.1M | $170.8M | $124.1M | $82.8M | $57.9M |
| SG&A Expense | $663.4M | $574.0M | $506.5M | $287.1M | $272.7M | $287.1M | $184.3M | $148.3M | $101.9M | $148.3M | $101.9M | $64.3M | $44.9M |
| R&D Expense | $89.8M | $94.8M | $84.4M | $90.0M | $51.7M | $90.0M | $31.7M | $23.9M | $18.0M | $23.9M | $18.0M | $15.6M | $14.1M |
| Operating Income | $189.2M | $9.3M | $73.6M | -$38.9M | $47.5M | -$38.9M | $1.2M | -$1.4M | $4.2M | -$1.4M | $4.2M | $3.0M | -$1.1M |
| Interest Expense | - | - | $1.7M | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $27.4M | $6.9M | -$11.3M | -$18.8M | $3.1M | -$18.8M | -$3.6M | -$15.7M | $1.7M | -$15.7M | $1.7M | $894.0K | -$5.4M |
| Net Income | $177.7M | $14.0M | $91.0M | -$15.7M | $48.5M | -$15.7M | $4.7M | $14.8M | $2.4M | $14.8M | $2.4M | $2.2M | $4.1M |
| EPS (Basic) | $2.37 | -$0.05 | $0.14 | -$0.44 | $1.39 | $0.19 | $0.14 | $0.49 | $0.09 | -$0.18 | $0.21 | -$0.18 | $0.21 |
| EPS (Diluted) | $2.32 | -$0.05 | $0.14 | -$0.44 | $1.34 | $0.18 | $0.13 | $0.44 | $0.08 | -$0.18 | $0.14 | -$0.18 | $0.14 |
| Shares Outstanding | 38.5M | 38.7M | 38.1M | 37.6M | 36.4M | 35.0M | 34.4M | 33.7M | 31.1M | 29.9M | 4.7M | 4.6M | 6.5M |
| Gross Margin | 67.1% | 63.2% | 64.5% | 60.3% | 68.0% | 60.3% | 65.1% | 64.9% | 66.7% | 64.9% | 66.7% | 66.0% | 65.1% |
| Operating Margin | 13.5% | 0.8% | 7.0% | -7.0% | 8.7% | -7.0% | 0.4% | -0.5% | 2.3% | -0.5% | 2.3% | 2.4% | -1.3% |
| Profit Margin | 12.7% | 1.2% | 8.6% | -2.8% | 8.8% | -2.8% | 1.4% | 5.6% | 1.3% | 5.6% | 1.3% | 1.8% | 4.6% |